Invention Grant
![Imidazo[2,1-b ]-1,3,4-thiadiazole sulfonamides](/docs/US/2010-05-11/US07714003B2/abs.jpg.600x600.jpg)
- Patent Title: Imidazo[2,1-b ]-1,3,4-thiadiazole sulfonamides
- Patent Title (中): 咪唑并[2,1-b] -1,3,4-噻二唑磺酰胺
-
Application No.: US11797663Application Date: 2007-05-07
-
Publication No.: US07714003B2Publication Date: 2010-05-11
- Inventor: James B. Jaquith , Alain Boudreault , Stephen J. Morris , Jon Durkin , John W. Gillard , Kimberley E. Hewitt
- Applicant: James B. Jaquith , Alain Boudreault , Stephen J. Morris , Jon Durkin , John W. Gillard , Kimberley E. Hewitt
- Applicant Address: CA Montreal, Quebec
- Assignee: Aegera Therapeutics Inc.
- Current Assignee: Aegera Therapeutics Inc.
- Current Assignee Address: CA Montreal, Quebec
- Agency: Rogers & Gray LLP
- Priority: CA2364985 20011214
- Main IPC: A61K31/41
- IPC: A61K31/41 ; A61K9/20 ; A61K9/48
![Imidazo[2,1-b ]-1,3,4-thiadiazole sulfonamides](/abs-image/US/2010/05/11/US07714003B2/abs.jpg.150x150.jpg)
Abstract:
This invention relates to compounds of Formula I and the use of compounds of Formula I as neuroprotective agents in the treatment of neuronal disorders of the central and peripheral nervous systems. Formula I:
Public/Granted literature
- US20070265319A1 Imidazo[2,1-b]-1,3,4-thiadiazole sulfonamides Public/Granted day:2007-11-15
Information query
